Clinical Trials Logo

Clinical Trial Summary

This study is a phase III clinical trial to evaluate the immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine (multivalent conjugate) in infants aged 2 months (at least 6 weeks) and 3 months. The main objectives of the study include: 1. To evaluate the immunogenicity of the trial vaccine in infants aged 2 months (at least 6 weeks) following the corresponding immunization schedule compared to the control vaccine; 2. To evaluate the immunogenicity of the trial vaccine in infants aged 3 months following the corresponding immunization schedule compared to the 2-month group; 3. To evaluate the safety of the trial vaccine in infants aged 2 months (at least 6 weeks) and 3 months following the corresponding immunization schedule.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05759520
Study type Interventional
Source Fosun Adgenvax Biopharmaceutical Co.,Ltd.
Contact Tianjing Wang
Phone +86 02885155331
Email wangtianjing@fosunpharma.com
Status Recruiting
Phase Phase 3
Start date November 4, 2022
Completion date June 30, 2025

See also
  Status Clinical Trial Phase
Recruiting NCT05060146 - Prevention of Pneumococcal Infections: Impact Collaborative Medico-pharmaceutical Care Structured to Improve Vaccination Coverage of Patients at Risk. N/A
Not yet recruiting NCT05017519 - Epidemiology and Household Transmission of Streptococcus Pneumoniae and Respiratory Syncytial Virus
Completed NCT05361499 - A Controlled Human Pneumococcal Infection Model (PIM) Study N/A
Active, not recruiting NCT03489018 - The Effect of Fractional Doses of Pneumococcal Conjugate Vaccines on Immunogenicity and Carriage in Kenyan Infants Phase 4
Completed NCT03696303 - Determination of the Utility of Pfizer's Pneumococcal Urine Antigen Test in Children 5 Years of Age or Younger With Community Acquired Pneumonia in Guatemala
Active, not recruiting NCT03102840 - Understanding Pneumococcal Carriage and Disease 2017-2020
Completed NCT00189020 - Effect of Two Versus Three Pneumococcal Conjugate Vaccinations Phase 3
Completed NCT02037984 - Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-004) Phase 1/Phase 2
Recruiting NCT04944719 - Pneumococcal Nasopharyngeal Colonization as Predictor of Community-Acquired Pneumonia (CAP) in Adults With Chronic Diseases.
Completed NCT03384589 - CIRN Pneumococcal Conjugate Vaccine 1 vs. 2 Dose Priming Study Phase 2/Phase 3